摘要
背景:虽然临床维生素A缺乏症(VAD)是世界范围内发展的公共卫生问题,但受到很好的控制,边缘性维生素A缺乏症(MVAD)更是普遍存在,特别是在中国孕妇和学龄前儿童中。越来越多的证据表明,VAD参与了阿尔茨海默病(AD)的发病机制。然而,MVAD是否从早期开始,增加AD发展的风险尚未确定。 目的:本研究的目的是探讨MVAD对大鼠AD发病机制的长期影响。 方法:从母体MVAD大鼠产生MVAD模型,断奶后用MVAD饮食维持。将男性双侧注射聚集的淀粉样蛋白β(Aβ)1-42进入海马的CA3区域,并检查与AD相关的认知和神经病理学表型。 结果:我们发现MVAR喂养显着加重了Morris水迷宫测试中Aβ1-42诱导的学习和记忆缺陷。在Aβ1-42注射的大鼠中,MVAD不诱导维甲酸受体(RARs),解联蛋白和金属蛋白酶10(ADAM10)或胰岛素降解酶(IDE)的mRNA表达。此外,RARα和RARγmRNA与ADAM10 mRNA呈正相关,而RARβmRNA与IDE mRNA呈正相关。 结论:我们的研究表明,从胚胎期开始的MVAD扰乱了AD相关基因,导致发展AD的风险增加。
关键词: 阿尔茨海默病,淀粉样蛋白β,维生素A,边缘维生素A缺乏症,记忆障碍,视黄酸受体,ADAM10,IDE。
Current Alzheimer Research
Title:Marginal Vitamin A Deficiency Exacerbates Memory Deficits Following Aβ1-42 Injection in Rats
Volume: 14 Issue: 5
关键词: 阿尔茨海默病,淀粉样蛋白β,维生素A,边缘维生素A缺乏症,记忆障碍,视黄酸受体,ADAM10,IDE。
摘要: Background: Although clinical vitamin A deficiency (VAD), which is a public health problem developing throughout the world, has been well controlled, marginal vitamin A deficiency (MVAD) is far more prevalent, especially among pregnant women and preschool children in China. Increasing evidence suggests that VAD is involved in the pathogenesis of Alzheimer’s disease (AD). However, whether MVAD, beginning early in life, increases the risk of developing AD has yet to be determined.
Objective: The goal of this study was to investigate the long-term effects of MVAD on the pathogenesis of AD in rats. Method: An MVAD model was generated from maternal MVAD rats and maintained with an MVAD diet after weaning. The males were bilaterally injected with aggregated amyloid β (Aβ)1–42 into the CA3 area of the hippocampus, and the AD-associated cognitive and neuropathological phenotypes were examined. Results: We found that MVAD feeding significantly aggravated Aβ1-42-induced learning and memory deficits in the Morris water maze test. MVAD did not induce the mRNA expression of retinoic acid receptors (RARs), a disintegrin and metalloprotease 10 (ADAM10) or insulin-degrading enzyme (IDE) in Aβ1-42-injected rats. Moreover, RARα and RARγ mRNA were positively correlated with ADAM10 mRNA, whereas RARβ mRNA was positively correlated with IDE mRNA. Conclusion: Our study suggests that MVAD beginning from the embryonic period perturbs the ADassociated genes, resulting in an enhanced risk of developing AD.Export Options
About this article
Cite this article as:
Marginal Vitamin A Deficiency Exacerbates Memory Deficits Following Aβ1-42 Injection in Rats, Current Alzheimer Research 2017; 14 (5) . https://dx.doi.org/10.2174/1567205013666161223162110
DOI https://dx.doi.org/10.2174/1567205013666161223162110 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Evaluation of the Anticancer Activities of the Plant Alkaloids Sanguinarine and Chelerythrine in Human Breast Adenocarcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry Protein Oxidative Folding in the Intermembrane Mitochondrial Space: More than Protein Trafficking
Current Protein & Peptide Science Hsp20 Protects Neuroblastoma Cells from Ischemia/Reperfusion Injury by Inhibition of Apoptosis via a Mechanism that Involves the Mitochondrial Pathways
Current Neurovascular Research Protective Substances Against Zinc-Induced Neuronal Death after Ischemia:Carnosine as a Target for Drug of Vascular Type of Dementia
Recent Patents on CNS Drug Discovery (Discontinued) Endocannabinoids and their Involvement in the Neurovascular System
Current Neurovascular Research Radiation and Gene Therapy: Rays of Hope for the New Millennium?
Current Gene Therapy Meet Our Editorial Board Member
Mini-Reviews in Medicinal Chemistry Calcitonin-Derived Carrier Peptides
Current Pharmaceutical Design Protein Kinase C Pharmacology: Perspectives on Therapeutic Potentials as Antidementic and Cognitive Agents
Recent Patents on CNS Drug Discovery (Discontinued) Emerging Role of JNK in Insulin Resistance
Current Diabetes Reviews Design, Synthesis, and Anti-Neuroinflammatory Activity of Amide- Containing Dithiolethiones
Medicinal Chemistry Using Cell Cultures for the Investigation of Treatments for Attention Deficit Hyperactivity Disorder: A Systematic Review
Current Neuropharmacology Aurora A and B Kinases - Targets of Novel Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores
Current Organic Chemistry Neuroprotection by Resveratrol in Diabetic Neuropathy: Concepts & Mechanisms
Current Medicinal Chemistry Preventing Prion Pathogenicity by Targeting the Cellular Prion Protein
Infectious Disorders - Drug Targets α-Synuclein Misfolding and Neurodegenerative Diseases
Current Protein & Peptide Science Evaluation of Anticancer, Antibacterial and Antioxidant Properties of a Medicinally Treasured Fern Tectaria coadunata with its Phytoconstituents Analysis by HR-LCMS
Anti-Cancer Agents in Medicinal Chemistry Triterpenoid Saponins from Two Panax japonicus Varietals Used in Tujia Ethnomedicine
Current Traditional Medicine Focus on MicroRNAs as Biomarker in Pediatric Diseases
Current Pharmaceutical Design